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Available online 17 May 2016Alpha-hemolysin (HlyA) is a hemolytic and cytotoxic protein secreted by uropathogenic Escherichia coli strains,
whose expression correlates with the severity of the infections produced. HlyA is synthesized as a protoxin,
ProHlyA, that becomes matured to the active form in the cytosol by hemolysin-C–directed fatty acylation at
the ε-amino residues of Lys 564 and Lys 690, before export from the toxin-producing bacteria. This posttransla-
tionalmodiﬁcation is remarkable because the nature of the protein is changed by the lipidicmoiety from a benign
protein to a frank toxin.
In the present work, we demonstrated for the ﬁrst time that, despite being hemolitically inactive, ProHlyA in-
duced cellular morphologic changes in rabbit erythrocytes. A discocyte-to-echinocyte transformation was trig-
gered by the protoxin in the absence of any accompanying increase in intracellular-Ca2+ levels. In addition,
the Ca2+-inﬂux kinetics in HlyA-treated erythrocytes indicated that the active toxin induced an elevation in
intraerythrocyte-Ca2+ content in a biphasicmanner, with an initial rise in Ca2+ that depended on the association
of the protein with the target membrane and a second increment corresponding to an activation of purinergic
channels. The ﬁrst increase was sufﬁcient to trigger a discocyte-echinocyte-spherocyte transition in erythrocyte
shape, though the subsequent rise mediated by purinergic signalling was essential for the occurrence of hemoly-
sis. The results presented here provide new insights into the mechanism of action of this toxin.
© 2016 Published by Elsevier B.V.Keywords:
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Alpha hemolysin (HlyA) is a hemolytic and cytotoxic protein secret-
ed by the uropathogenic strains of Escherichia coli. This toxin is active
against a broad range of species and cell types. Quantiﬁcation of HlyA
phenotypes among commensal E. coli isolates revealed that 15% encode
HlyA;with the degree of expression of that gene correlatingwith the se-
verity of infection, as up to 78% of the uropathogenic-E. coli isolates from
pyelonephritis cases express this toxin [1,2].
HlyA represents the prototype of a wide range of toxins referred to
as the RTX-toxin family (i. e., Repeat in toxin). Produced by a variety
of Gram-negative bacteria, these proteins exhibit two common features.
The ﬁrst is the presence of arrays of glycine- and aspartate-rich
nonapeptide repeats, which sequences are located at the C-terminus.
The second is the unique mode of secretion via the type-I system (anMédicas, Universidad Nacional
).ABC-binding–cassette transporter) [3–5]. The RTX-operon arrangement
of the genes required for HlyA expression, activation, and secretion is
hlyCABD, with the tolC gene at an independent locus [6–9]. The HlyC
protein is an acyltransferase required for the activation of HlyA in the
bacterial cytosol before the toxin's secretion. HlyA is initially synthe-
sized as a protoxin (ProHlyA), with its activation consisting in a post-
translational modiﬁcation of the ε-amino groups of internal lysine
residues by amide-linkage to fatty-acyl moieties. The mechanism of
this novel type of protein acylation has been extensively analyzed for
HlyA [8,10]. HlyC uses the fatty-acyl residues carried by the acylcarrier
protein to form a covalent acyl-HlyC intermediate, which species then
transfers the fatty-acyl residues to the ε-amino groups of the Lys 564
and Lys 690 residues of ProHlyA [11,12]. Acylation is not required for
membrane binding, but the lipidic modiﬁcation is essential for the sub-
sequent lysis of the target cells [13,14]. This posttranslational alteration
is remarkable in that the behavior of the protein becomes changed
through this lipidic linkage from a benign protein to a frank toxin—with
that part of the transformation being an especially unusual mechanism
in prokaryotes since in only a few eukaryotic proteins is this type of
acylation found [15].
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have been conductedwith erythrocytes as target cells [13,16–18], to cite
but a few. In recent years, Skals et al. introduced the idea of how auto-
crine and paracrine signalling alongwith the cell's intrinsic volume reg-
ulation markedly inﬂuences the fate of erythrocytes after membrane
interaction with HlyA [19–21]. Those authors demonstrated with
equine, murine, and human erythrocytes that cellular-ATP leakage and
Ca2+ inﬂuxes through the interaction of HlyA activate purinergic recep-
tors and pannexin channels [20]. This activation further potentiates the
inﬂux of extracellular Ca2+ and contributes to the shrinkage and crena-
tion of erythrocytes that result from the activation of Ca2+-dependent
K+ channels (i. e., the Gardos K+-speciﬁc channels) and the Ca-
activated Cl− channel TMEM16A [19]. This intracellular-Ca2+ increase
also activates the calpain neutral proteases that hydrolyze cytoskeletal
proteins, thus contributing to changes in the erythrocyte morphology
[22]. Recently, we were able to quantify the intracellular-Ca2+ concen-
tration in rabbit erythrocytes treated with HlyA by ﬂuorescence
lifetime-imaging microscopy [23]. By that technique, we demonstrated
that intracellular Ca2+ increases fourfold inHlyA-treated erythrocytes be-
fore the occurrence of hemolysis—and in a biphasic manner—suggesting
that different mechanisms were involved in the rise in Ca2+.
In viewof these considerations, the presentwork focussed on the in-
teraction of the unacylated form of HlyA (i. e., the ProHlyA) with rabbit
erythrocytes by monitoring cell morphology and the intraerythrocyte-
Ca2+ levels after treatment with the toxin. Microscopical imaging and
ﬂow-cytometry demonstrated that although ProHlyA causes neither
Ca2+ inﬂux nor the lysis of rabbit erythrocytes, that protoxin induces
cellular morphologic alterations. These changes could be caused by
the association of the protein with the erythrocyte membrane since
the unacylated inactive protein precursor produces the same effects in
terms of increments in the surface pressure of lipidmonolayersmimick-
ing the outer leaﬂet of rabbit-erythrocytemembranes as does the active
HlyA. These ﬁndings provide new insights into themechanism of action
of the active toxin HlyA.
2. Materials and methods
2.1. Materials
HlyA and ProHlyA were puriﬁed from culture ﬁltrates of the E. coli
strains WAM 1824 [24] and WAM 783 [18], respectively, following the
procedure described previously [25].
Lipids, 1,2-dioleoyl-sn-glycero-3-phosphocholine (DOPC), N-
palmitoyl-D-erythro-sphingosylphosphorylcholine (16:0-SM), and cho-
lesterol (Chol), were purchased from Avanti Polar Lipids (Birmingham,
AL, USA); Fluo-4 acetoxymethyl ester (AM), from Molecular Probes,
Inc. (Eugene, OR, USA), and ionomycin, bovine serum albumin, Brilliant
Blue G (BBG), NiCl2, and the other reagents, unless indicated to the
contrary, from Sigma-Aldrich (St. Louis, MO, USA). The HEPES- [4-(2-
hydroxyethyl)-1-piperazineethanesulfonic acid-] buffered saline
(HBS) contained (in mM): 135 NaCl, 10 HEPES, 5.3 KCl, 2.0 CaCl2, 1.0
MgSO4, 5.0 glucose, pH 7.4.
2.2. Erythrocyte preparation
Blood samples were obtained at the laboratory-animal facility of
the Instituto de Biotecnología, UNAM, in strict accordance with the
technical speciﬁcations of the Mexican Ofﬁcial Standard NOM-062-
ZOO-1999 and the international ethical guidelines for the care and use
of laboratory animals.
Blood from healthy rabbits was obtained by venipuncture and
anticoagulated by manual deﬁbrination. The total erythrocyte popula-
tion was separated from other blood components by centrifugation at
1500g for 10 min at 15 °C and washed three times by centrifuging
with 0.9% (w/v) NaCl. After the last wash, the packed erythrocytes
were resuspended in Alsever's solution (Sigma Chemical Co., St. Louis,MO, USA) and stored at 4 °C. The erythrocytes were used within the
ﬁrst two days after extraction.2.3. Hemolytic assays
Measurements of hemolytic activity were performed by adding
100 μl of a 2% (v/v) erythrocyte suspension in HBS buffer to 100 μl of
toxin dilutions in a microtiter plate. After 30 min at 37 °C, the plates
were centrifuged and the hemolysis quantiﬁed as released hemoglobin
by measuring the absorbance at 412 nm.
For the lysis-inhibition assays erythrocyte suspensions were
pretreated with 4.0 mM NiCl2 or 20 μM BBG in HBS buffer for 30 min
at 37 °C. Then 100 μl of these suspensions were added to the toxin dilu-
tions to perform the hemolytic assays.
For measuring the hemolytic activity of ProHlyA in the presence of
ATP, HBS buffer containing 6.0 or 2.0 mM of ATP, pH 7.4, was used to
prepare the protein dilutions. Then the erythrocyte suspension in HBS
was added to each well as stated above to perform the assays.2.4. Live-cell imaging
Erythrocytes were attached to glass coverslips mounted on custom-
made imaging chambers by sedimentation from 0.02% (v/v) suspen-
sions for 5min. For intracellular-Ca2+ imaging, erythrocyte suspensions
(1% [v/v]) were incubated with Fluo-4 AM (1 μM) for 60 min at 37 °C
with constant gentle stirring in the dark. The cells were next washed
twice, resuspended in HBS buffer, and then attached to the coverslips.
In all these experiments 0.05% (w/v) bovine-serum albumin was
added to the buffer to avoid crenation of the erythrocytes as they
came in contact with the glass [26].
Imaging chambers were placed on the stage of an Eclipse TE2000U
microscope (Nikon Instruments, Melville, NY, USA). Erythrocytes were
imaged with a CFI Apo TIRF 60×/1.49 N.A., oil-immersion objective
(Nikon) and an iXon Ultra 897 EMCCD camera (Andor Technology, Bel-
fast, NIR, UK). A blue light-emitting diode (470 nm) powered by
OptoLED, both from Cairn Research Company (Faversham, Kent, UK),
and a ﬁlter set of HQ480/40× for excitation and of D535/40m for emis-
sion (Chroma Technology, Rockingham, VT, USA) were employed to
measure the Fluo-4 ﬂuorescence. Images were captured through the
use of the Andor iQ software (Andor Technology). Time-lapse record-
ings of the erythrocytemorphology or Fluo-4 ﬂuorescencewere collect-
ed at different times after the addition of HlyA or ProHlyA at a sampling
rate of 0.1 Hz. The same technical set upwas used for experiments in the
presence of 2 mM NiCl2 or 10 μM BBG.
Changes in erythrocyte-ﬂuorescence intensity were calculated by
marking regions of interest around the cells by means of ImageJ soft-
ware [27]. Themean ﬂuorescence intensitywasmeasured for individual
cells at each time point and the values corrected by subtracting the
mean ﬂuorescence in the background of that region at the same instant.2.5. Analyses on the ImageStream® MkII Imaging Flow Cytometer
A 0.5% (v/v) suspension of erythrocytes loaded with Fluo-4 AM
(5 μM)was treatedwith 70 and 7 nMof ProHlyA andHlyA, respectively.
Image acquisition and analysis were performed on an ImageStream®
MkII imaging cytometer, through the use of INSPIRE software. The in-
strument and software were set up as follows: Channels 01 (bright
ﬁeld), 02 (ﬂuorescence channel) and channel 12 (scattering channel).
The magniﬁcation was 60×, providing a pixel size of 0.3 μm2, while
the lasers 488 and 745 were activated for ﬂuorescence and side-
scatter, respectively. The acquisition cut-off was set to 10,000. The anal-
ysis of the data was performed by means of the IDEAS software (Amnis
Corp., Seattle, WA, USA).
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Surface-pressure experiments were carried out with a KSV NIMA
Langmuir-trough Model 102A (KSV-NIMA Biolin Scientiﬁc, Espoo,
Finland)with aWilhelmyplatinumplate as the surface-pressure sensor.
The aqueous subphase consisted of (in mM) 20 Tris, 150 NaCl, pH 7.4
(TC Buffer) plus 2.0 CaCl2. The ternary lipid mixture DOPC/16:0-SM/
Chol at a 2:1:1 molar ratio dissolved in chloroform was gently spread
over the surface of a Teﬂon microtrough containing only 300 μl of sub-
phase until the desired initial surface pressure was attained. HlyA or
ProHlyA at 40 nM ﬁnal concentration were then injected into the sub-
phase bulk with a micropipette. The increment in surface pressure ver-
sus time was recorded until a stable signal was obtained. All the
experiments were carried out at 20 ± 1 °C.2.7. Statistical analysis
The Student t-test was used for statistical comparisons among the
groups and differences were considered statistically signiﬁcant when
p b 0.05 (*p b 0.05, **p b 0.01, ***p b 0.001).Fig. 1. Hemolytic activity of HlyA and ProHlyA in rabbit erythrocytes. Panel A: The hemolysis o
different concentrations of the proteins. In theﬁgure, the percent hemolysis is plotted on the ord
circles, HlyA; open circles, ProHlyA. The data represent themean± SEM of 3 independent expe
erythrocytes taken before (time 0) and 5, 15, or 40 min (indicated above the ﬁgure) after th
corresponding to control erythrocytes (lower row) pertain to the same time points after the
without the protein. Panel C: Percentage of unlysed cells (ﬁlled circles) and crenated cells
ProHlyA (right ﬁgure). Bright-ﬁeld images were analyzed over time after exposure to the pro
plotted on the ordinate as a function of time in min on the abscissa. The data represent th
experiments with blood from 2 different animals.3. Results
3.1. Morphologic changes of erythrocytes treated with HlyA and ProHlyA
Many experiments have been carried out with erythrocytes from
different animal species in order to study the lytic mechanism of HlyA
[17,19,28,29]; nevertheless, beyond the nonhemolytic activity reported
for ProHlyA, the effect of this unacylated precursor on erythrocytes has
been poorly investigated. In view of this shortcoming, the action of both
proteins, HlyA and ProHlyA, were accordingly studied in rabbit erythro-
cytes. Fig. 1, Panel A depicts the hemolysis of 2% (v/v) of rabbit-
erythrocyte suspensions treated with HlyA and ProHlyA. As had been
previously demonstrated, HlyA effectively lysed erythrocytes in a
dose-dependent fashion, but ProHlyA produced no hemolysis at any
concentration tested. When hemolysis was monitored by optical mi-
croscopy, morphologic changes were observed in HlyA- and also, quite
strikingly, in ProHlyA-treated cells (Fig. 1, Panel B).Microscopywas per-
formed over time after treatment with 5 nM of HlyA (n = 4 from 2
blood samples). At this toxin concentration an erythrocyte lysis of 75%
was observed after 40min (Fig. 1, Panel C). HlyA induced ﬁrst the crena-
tion of these rabbit erythrocytes, followed by a swelling and lysis of thef HlyA and ProHlyA was measured as the hemoglobin released after a 30-min exposure to
inate as an exponential function of the concentration of protein in nMon the abscissa. Filled
rimentswith blood from 3 different animals. Panel B: Representative bright-ﬁeld images of
e addition of 5 nM of HlyA (upper row) or 50 nM of ProHlyA (middle row). The images
addition of a volume of buffer equal to that added to the HlyA and ProHlyA samples, but
(open circles) at different times after the addition of 5 nM HlyA (left ﬁgure) or 50 nM
teins to assess the cell counts. In the ﬁgures the percentage of cells in either condition is
e means ± SEM of n = 4 images for each time point corresponding to independent
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et al. [19,20].When the same concentration of ProHlyAwas tested,mor-
phologic changes were also observed, but at longer time intervals (not
shown). In contrast, when the concentration of the protoxin was in-
creased by tenfold over that used with HlyA, ProHlyA induced an initial
crenation of the erythrocyteswithin 5min,with this alteration reaching
100%within 10min. No further changes in morphology, however, were
observed thereafter, as the erythrocytes remained mostly in an
echinocytic shape over time and neither swellednor lysed (Fig. 1, Panels
B and C). Images of the control erythrocytes were taken over the same
time course, thus conﬁrming that these changes were caused by the
HlyA or ProHlyA treatment since no such morphologic alterations
were observed in the absence of those proteins (Fig. 1, Panel B). These
ﬁndings indicate that, unlikewhatwould have been expected from pre-
vious results, the interaction of ProHlyA with erythrocyte membranes
may trigger cellular responses that lead to morphologic changes in the
cell even though those responses do not produce lysis.
3.2. Measurement of intracellular-Ca2+ levels in HlyA- and ProHlyA-
treated erythrocytes
Skals et al. postulated that the induction of shrinkage in human
erythrocytes produced by HlyA resulted from the activation of Ca2+-
activated K+ channels (i. e., the Gardos channels) [19]. In agreementFig 2. Calcium inﬂux in HlyA- or ProHlyA-treated erythrocytes. Panel A: Changes in intracellula
ﬁgure) as visualized by ﬂuorescence imaging of the Ca2+ sensor Fluo-4 (excitation at 470 nm; e
u.) per cell is plotted on the ordinate as a function of time inmin on the abscissa. Each ﬁgure show
ofﬂuorescence images through the use of ImageJ software as described inMaterials andmethod
intensity of untreated cells (Control, N=83) and of ProHlyA- (N=98), or HlyA- (N=128) trea
cells (Iono, N=87) set as a 100% increase. For Control and ProHlyA treatment, the rise inﬂuores
cells the elevation was measured at the maximum of ﬂuorescence intensity observed, just b
independent experiments with blood from 3 different animals. Panel C: Bright-ﬁeld (upper ro
(right ﬁelds) after the addition of 50 nM ProHlyA. An image of the same sample after a 40-m
ionomycin is also shown as the ﬂuorescence-positive control for Fluo-4–loaded cells (adjace
after the addition of 10 nM HlyA (at 30 and 50 min, indicated below the ﬁgure). The images a
each of the two proteins with blood obtained from 3 different rabbits.with this proposal, we had previously observed an increment in
intraerythrocyte-Ca2+ levels occurring before the hemolysis of rabbit
erythrocytes treated with HlyA that could explain the shrinkage found
in those HlyA-treated cells. Therefore, in order to investigate if Ca2+
ions were involved in the discocyte-to-echinocyte–shape transition
found in ProHlyA-treated cells, we monitored the inﬂux of Ca2+ in
Fluo-4–loaded rabbit erythrocytes after treatment with ProHlyA or
HlyA. Fig. 2, Panel A illustrates how an HlyA-induced increase in Ca2+
levels occurs in a biphasic manner, as we had demonstrated previously
[23]. An initial sharp elevation was observed within 5 to 8 min of HlyA
interactionwith the erythrocytes. Then a slower, sustained rise followed
until the point of cellular hemolysis after 25–35 min. This pattern is in
agreement with the data presented in Fig. 1, Panel C, where a 50%
decay in the number of erythrocyteswas observed after 35min of expo-
sure to HlyA. In contrast, ProHlyA induced no intracellular-Ca2+ in-
crease whatsoever (Fig. 2, Panels A–C). Since the ProHlyA-induced
crenation of the erythrocytes was independent of an increase in Ca2+,
responses other than Gardos-channel activation must be involved in
themorphologic changes observed. Furthermore,when the HlyA hemo-
lytic activity was monitored in Ca2+-free buffer (10 mM HEPES,
150 mM NaCl, 5 mM EDTA, pH 7.4), the same behavior as seen with
ProHlyAwas observed (Fig. 2, Panel D). Under these conditions, the rab-
bit erythrocytes likewise became transformed from the discocyte to the
echinocyte shape and remained in that morphology thereafter in ther-Ca2+ levels in single cells in response to 5 nMHlyA (left ﬁgure) or 50 nM ProHlyA (right
mission at 535/40 nm). In the ﬁgures, themean ﬂuorescence intensity in arbitrary units (a.
s representative records obtained in single cells (colored curves) in a time-course analysis
s. Panel B: The bar graphs plot on the ordinate the average increment inmean ﬂuorescence
ted cells normalizedwith respect to the average elevation observed for ionomycin-treated
cence intensity increasewasmeasured after 40min of image acquisition. For HlyA-treated
efore the occurrence of hemolysis. The data represent the mean values ± SEM from 5
w) and ﬂuorescence-intensity (lower row) images before (time 0, left ﬁelds) and 40 min
in exposure to ProHlyA with the subsequent addition of a 1 μM ﬁnal concentration of
nt right ﬁelds). Panel D: Images of erythrocytes in Ca2+-free buffer before (time 0) and
s well as the ﬂuorescence kinetics are representative of N5 independent experiments for
1948 R.F. Vázquez et al. / Biochimica et Biophysica Acta 1858 (2016) 1944–1953absence of any cell lysis, thus conﬁrming the notion that Ca2+ entry is
not strictly necessary for erythrocyte crenation to occur under the inﬂu-
ence of the toxin.
With the aim at studying further the relationship between increases
in intracellular Ca2+ and morphologic changes in HlyA- and ProHlyA-
treated erythrocytes, we performed ﬂow-cytometry analysis in an
ImageStream® MkII Imaging Flow Cytometer since this technology had
the overwhelming advantage of allowing the observation of each indi-
vidual event passing through the ﬂow cell. Fig. 3 shows the histograms
of ﬂuorescence intensity corresponding to Fluo-4–loaded rabbit eryth-
rocytes at different times after treatment with both proteins. The ﬁgure
clearly shows that ProHlyA induced cellular morphologic alterations in-
volving a conversion of the erythrocytes to an echinocytic shape even
though no increment in ﬂuorescence was observed, thus reconﬁrming
the results obtained by ﬂuorescence-microscopy imaging. The histo-
grams corresponding to HlyA-treated erythrocytes indicated the pres-
ence of different populations of cells differing in their ﬂuorescence
intensity. The group of cells with the highest ﬂuorescence intensity
(similar to that observed for ionomycin-treated erythrocytes)
corresponded to spherocytes, as visualized in the bright-ﬁeld channel
(cf. the upper insets in the ﬁgures), while the population with interme-
diate ﬂuorescence intensity corresponded to echinocytic cells (the
lower insets in the ﬁgures). After 40 min of exposure to HlyA, a third
population appeared with a very low ﬂuorescence intensity that could
be attributed to erythrocyte ghosts (the lowest inset in that ﬁgure).
We do, however, recognize that because Fluo-4 is a nonratiometric
Ca2+ indicator, the ﬂuorescence-intensity emission observed could be
affected by the cellular morphologic changes occurring in the treated
erythrocytes per se since both the Ca2+-ion and the Fluo-4 concentra-
tions could be modiﬁed as a result of the accompanying volume
changes.
Fig. 4 shows a scatter plot of channel-02–ﬂuorescence intensity plot-
ted against the area for each cell treated for 40 min with ProHlyA or
HlyA. The echinocyte population depicted for HlyA in Fig. 3, occupies a
slightly smaller area than the control erythrocytes, which area is similar
to the area of echinocytes induced by ProHlyA, but the ﬂuorescenceFig. 3. Flow-cytometry analysis of HlyA- and ProHlyA-treated rabbit erythrocytes. Rabbit ery
acquisition and ﬂuorescence-data analysis performed on an ImageStream® MkII imaging cy
cells) on the ordinates as a function of the Fluo-4–ﬂuorescence-signal intensity in arbitrary un
exposure to 70 or 7 nM of ProHlyA (upper row) or HlyA (lower row), respectively (indicated
ProHlyA with the subsequent addition of 5 μM of ionomycin (Iono) is also shown as a control
ﬂuorescence (black background; excitation at 488 nm) images of rabbit erythrocytes corres
beside (with a single peak) or directly above (with double peaks or triple peaks) the res
experiments with blood from two different animals.intensity of the former is nearly twofold higher than that of the latter
(Fig. 4). This feature could account for the rapid series of steps that
take place after HlyA treatment, where certainly a number of these
echinocytes might have already started the transformation to
spherocytes as a result of Ca2+ entry. That, however, ProHlyA-treated
erythrocytes, which population remained as echinocytes over time,
maintained their ﬂuorescence-intensity level similar to those of the
control cells is indeed noteworthy. In contrast, in the HlyA-treated
erythrocytes, the cell population with a high ﬂuorescence intensity cor-
responding to spherocytes, showed a signiﬁcant reduction in area (15%)
compared to control erythrocytes and crenated cells. The same charac-
teristic was found in erythrocytes after addition of ionomycin
conﬁrming that the echinocyte-to-spherocyte–shape transition is ac-
companied by a reduction in cell dimensions. Moreover, erythrocyte
ghosts which appeared as a result of cell lysis also exhibited very low
areas.
According to a recent report, purinergic ampliﬁcation is needed for
lysis of HlyA-treated erythrocytes since different P2-channel blockers
abrogate hemolysis in human, murine and equine red-blood cells [20].
Considering this ﬁnding, we monitored the hemolytic activity in rabbit
erythrocytes after HlyA addition in the presence of Ca2+-channel
blockers. Accordingly, the voltage-gated–Ca2+-channel blocker Ni2+
and the P2-receptor antagonist BBG, both impaired HlyA lytic activity
in rabbit erythrocytes (Fig. 5, Panel A). Therefore, after treatment of rabbit
erythrocytes with HlyA in the presence of those channel blockers, and
thus under nonhemolytic conditions, cell morphology and Ca2+ levels
were monitored in order to compare those responses with the
corresponding behavior in ProHlyA-treated erythrocytes. Bright-ﬁeldmi-
croscopy revealed that under these conditions the erythrocytes still
underwent the discocyte-echinocyte-spherocyte–shape-transformation
sequence although the cells remained as spherocytes and did not swell
or lyse (Fig. 5, Panel C). Furthermore, when Ca2+-inﬂux kinetics were
analyzed by the Fluo-4 imaging of HlyA-treated erythrocytes in the
presence of these inhibitors, an increase in intraerythrocyte-Ca2+ levels
was still observed, though not following biphasic kinetics as before
(cf Fig. 2, Panel A) but instead involving only the ﬁrst rise in intracellularthrocytes loaded with Fluo-4 AM (5 μM) were treated with ProHlyA or HlyA and image
tometer (N = 10,000). The histograms plot the frequency of events (i. e., the passage of
its on the abscissas for untreated cells (Control) and erythrocytes after 10 and 40 min of
above the ﬁgures). The histogram corresponding to cells after 40 min of interaction with
of Fluo-4 loading (upper row, extreme right ﬁgure). Bright-ﬁeld (gray background) and
ponding to each ﬂuorescence distribution in the histograms are shown as insets placed
pective ﬂuorescence distribution. The results are representative of two independent
Fig. 4. Fluorescence intensity and area analysis inHlyA- and ProHlyA-treated erythrocytes. In theﬁgures, the totalﬂuorescence intensity in arbitrary units per cell is plotted as a function of
the area (in μm2) for each cell measured in the ImageStream® MkII imaging cytometer. Each dot represents a single erythrocyte. The ﬁgure show the plots for untreated erythrocytes
(Control; left, upper row), cells after 40 min of exposure to ProHlyA (70 nM; left, lower row) or HlyA (7 nM right, lower row) as well as for ProHlyA-treated erythrocytes after the
addition of 5 μM of ionomycin (right, upper row). The ﬁgures are representative of two independent experiments with blood from two different animals.
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in the presence of Ni2+ or BBG underwent no changes in Fluo-4 ﬂuores-
cence or cell morphology over time, thus conﬁrming that those cellularFig. 5. Effects of Ca2+-channel inhibitors on HlyA activity. Panel A: Hemolytic activity of 5 nMH
Ca2+-channels inhibitors: the P2 antagonist Brilliant BlueG (BBG) at 10 μMor the voltage-gated
ordinate for each of the experimental conditions indicated on the abscissa. The data represent th
analyzed statistically by the Student t-test (***p b 0.001 compared to control values). Panel B: Er
(right ﬁgure). Each record corresponds to themean ﬂuorescence intensity of single cells (colore
on the ordinate, followed over the time in min indicated on the abscissa. The two ﬁgures pres
rabbits. Panel C: Bright-ﬁeld images of rabbit erythrocytes before (time 0) and 30min after theresponses were induced by the toxin (Supplementary Fig. 1). These re-
sults pointed out that a Ca2+ entry was triggered by HlyA treatment
through pathways that could not be blocked by those compounds. Thus,lyA in rabbit erythrocytes after 30min of exposure in the absence (Control) or presence of
–Ca2+-channel blockerNi2+ at 2mM. In the ﬁgure, the percent hemolysis is plotted on the
emean values± SEM of 3 independent experiments with blood from 2 different rabbits as
ythrocytes treatedwith 5 nMHlyA in the presence of 2mMNi2+ (leftﬁgure) or 10 μMBBG
d curves) in arbitrary units per cell (corrected for background ﬂuorescence), as designated
ent records representative of 4 independent experiments with blood from two different
addition of 5 nMHlyA in the presence of 2 mMNi2+ (left ﬁeld) or 10 μMBBG (right ﬁeld).
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might be related to an activation of purinergic channels, is responsible
for cell lysis.Fig. 6. Protein interaction with DOPC:SM:Chol monolayers. Time course of the interaction
of HlyA (black line) or ProHlyA (gray line)with lipidmonolayers ofDOPC/16:0-SM/Chol in
a 2:1:1 M ratio at an initial lateral pressure of 20 mN/m. The increase in surface pressure
was monitored after the injection of 40 nM ﬁnal concentration of the proteins into the
buffer-containing subphase (20 mM Tris, 150 mM NaCl, 2 mM CaCl2, pH 7.4). The
experiments were performed at 20 ± 1 °C. In the ﬁgure—consisting of representative
curves from 3 independent experiments—the increase in the monolayer's surface
pressure, Δπ, in mN/m is plotted on the ordinate as a function of time in seconds on the
abscissa.3.3. The effect of exogenous ATP on ProHlyA-treated erythrocytes
The results thus far have indicated that an activation of purinergic
receptors is responsible for the second elevation in Ca2+ concentration,
an increase that is necessary for the occurrence of hemolysis in rabbit
erythrocytes. Skals et al. have proposed that the interaction of HlyA
alone destabilized the membrane, thus inducing an ATP efﬂux through
the pore formed by the toxin, and that this ATP efﬂux was responsible
for the Ca2+-signal ampliﬁcation through activation of purinergic re-
ceptors [30]. That the interaction of ProHlyAwith the erythrocytemem-
brane does not produce cell lysis has been well established. Indirect
evidence has suggested that the lack of oligomerization and pore forma-
tion might be responsible for this hemolytic inactivity [13]. Following
this idea, we added exogenous ATP to ProHlyA-treated erythrocytes in
order to test if the membrane perturbation induced by the protoxin,
even though insufﬁcient to induce any Ca2+ inﬂux per se, could nev-
ertheless lead to hemolysis in the presence of exogenous ATP. The re-
sults demonstrated that the addition of exogenous ATP produced a
slight degree of hemolysis in ProHlyA-treated erythrocytes, although
no statistically signiﬁcant differences in the hemolytic activity were
found in the presence of 1 or 3 mM ATP compared to control exper-
iments without ATP. The hemolysis produced by 8 nM ProHlyA was
increased from 0.6 ± 0.3% in control experiments to 1.2 ± 0.4% and
1.6± 0.8% by the presence of 1 and 3mMATP, respectively. Notwith-
standing, this increment in hemolysis is far from being similar to the
marked lytic activity reported for exposure to 1 nMHlyA, which con-
centration already produced a 100% erythrocyte lysis (Fig. 1, Panel
A). These results indicate that the interaction of ProHlyA with the
membrane induces changes in the erythrocyte morphology; but, un-
like the altered state affected by HlyA, the ProHlyA conformational
structure is still not adequate either to form that putative pore or
to activate any transduction pathway that could ﬁnally lead to
hemolysis.3.4. Interaction of HlyA and ProHlyA with lipid monolayers
Lipid monolayers are extremely useful for studying lipid-protein
interactions because those model membranes permit a control of
the surface pressure and lipid density along with the subphase con-
tent and lipid composition. HlyA interaction with such membrane
models allowed the study of the adsorption and insertion phenome-
na in the absence of further changes in the lipid architecture because
the monolayer could not undergo the three-dimensional membrane
restructuring essential for altering the membrane-permeability bar-
rier [14]. In the following experiments the increase in surface pres-
sure (Δπ) caused by the interaction of HlyA or ProHlyA interaction
with a monolayer composed of DOPC:SM:Chol at a lateral pressure
of 20 mN/m was measured (Fig. 6). This lipid mixture was chosen
since it represents a lipid composition similar to that of the outer
hemilayer of erythrocyte membranes, as reported by us earlier [31,
32]. In this model experimental system, both proteins accordingly
produced an increase in surface pressure in the DOPC:SM:Chol
monolayers at an initial lateral pressure of 20 mN/m. The total sur-
face pressure increment achieved after the injection of 40 nM of
either protein was 3.1 ± 0.4 and 3.0 ± 0.6 mN/m for HlyA and
ProHlyA, respectively (Fig. 6).
These results suggest that despite the lack of lytic activity of ProHlyA,
the effect of the protoxin's physical interaction with the erythrocyte
membrane measured in terms of the resulting increment in surface
pressure was similar to that obtained for HlyA.4. Discussion
The E.coli HlyA is considered the prototype of the RTX family of
toxins. Members of this family share many structural characteristics,
amongwhich is the acylation of internal lysine residues [5,33]. In the ex-
ample of HlyA, the protoxin, ProHlyA, is matured in the cytosol to the
active form by HlyC-directed fatty acylation at the ε-amino groups of
the Lys 564 and Lys 690; which modiﬁcation changes the benign
protoxin to a frank toxin, before export from the producing bacteria.
Up to the present, ProHlyA has been considered a strictly benign precur-
sor, since the protoxin is hemolytically and cytolytically inactive [34,35],
even though ProHlyA has been found capable of binding to erythrocytes
to the same extent as HlyA [13,16]. In the present work, we have dem-
onstrated for the ﬁrst time that the interaction of ProHlyA with the
erythrocyte membrane causes crenation of the cells independently of
a Ca2+ inﬂux (Figs. 1–3). These ﬁndings have signiﬁcant implications
since the increase in Ca2+ levels in HlyA-treated erythrocytes, along
with the subsequent activation of the Gardos channels, has been largely
considered to be responsible for the subsequent erythrocyte shrinkage
and crenation [19]. The results obtained here, however, indicate that
the mere interaction of ProHlyA with the membrane causes these mor-
phologic changes since the unacylated precursor was not capable of in-
ducing any Ca2+ elevation in erythrocytes. The studies reported here on
protein-lipid interactions through the use of lipid monolayers as mem-
branemodel systems demonstrated that ProHlyA produced increases in
the surface pressure of lipid mixtures mimicking the outer leaﬂet of
rabbit-erythrocytes membranes similar to the elevations effected by
HlyA (Fig. 6).Moreover, in the absence of Ca2+ (Fig. 2, Panel D), cell cre-
nation was still observed in HlyA-treated erythrocytes, thus reinforcing
the notion that Ca2+ inﬂux is not strictly required for the earlymorpho-
logic changes that convert the discocytic erythrocyte into an echinocytic
shape. All these ﬁndings support the interpretation that protein-
membrane interactions per se may be responsible for the erythrocyte
crenation induced by both proteins.
In a very recent work we demonstrated that the increase in intracel-
lular Ca2+ induced byHlyA, activated calpains responsible for the prote-
olysis of spectrins, ankyrin, Band 3, and protein 4.1. [22]. At that time,
we proposed that the destabilization of the cytoskeleton might induce
the shrinkage of the erythrocytes. The results presented here indicated
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brane induced crenation of the cells since both proteins triggered
those cellular morphologic alterations; even though ProHlyA did not
produce any Ca2+ inﬂux, an indispensable condition for activating
calpains [36]. Nevertheless, the entry of Ca2+ ions that occurs after
HlyA-treatment of erythrocytes may contribute to these morphologic
changes through the activation of calpains and the subsequent
signalling cascades that lead to membrane cytoskeleton destabilization
and the spherocyte shape.
The monolayer technique is a widely used tool for studying protein-
membrane interactions. On the basis of studies on a series of proteins
with different tertiary structures, the increase in surface pressure of a
lipid monolayer has been postulated to result from either the insertion
of proteins or a conformational rearrangement of the proteins and lipids
in the adsorbed layer [37]. Therefore, the ﬁndings obtained here for the
interaction ofHlyA and ProHlyAwith thesemodelmembranesmust not
be considered as a direct indication of similar interactions on the part of
both proteinswith the lipidmonolayers. Even thoughHlyA and ProHlyA
both contain an amphipathic N-terminal region that may allow the in-
teraction of either protein with the membrane, the two have one main
structural difference: the presence of two fatty acids in the former. As
we have demonstrated before, both proteins present different confor-
mational structures in solution: HlyA exhibits a molten globule confor-
mation, promoted by the presence of the covalently bound fatty acids;
whereas ProHlyA assumes a more compact structure [38]. Therefore,
both proteinsmay interact with themembrane in different tertiary con-
formations; and thus, even though the changes in surface pressure
observed by the monolayer technique are similar, the nature of the
membrane perturbation —i. e., the number and extent of monomers
inserted, the type of protein and lipid rearrangements, or other
alterations—produced by the two proteins might still be different.
Thus, differences in the interaction of both proteinswith the erythrocyte
membranemay certainly have discrepant implications in the ﬁnal effect
produced. While the interaction of HlyA may lead to an activation of
transduction pathways that terminate in cell lysis, this same active
membrane conformation might not be attained by association with
ProHlyA, with only the early membrane-shape transitions occurring in
the absence of any triggering of further signalling cascades.
In order to explain the shape alterations induced by HlyA and
ProHlyA, the latter being independent of calcium inﬂux, we revised
the bilayer-couple hypothesis formulated by Sheetz and Singer [39,
40]. According to their hypothesis,membranes forming a closed surface,
whose proteins and polar lipids are asymmetrically distributed in the
two halves of the membrane bilayer, can act as bilayer couples—that
is, the two monolayers can respond differently to a perturbation while
remaining coupled to one another, with the observed shape alterations
arising from a differential expansion of the two monolayers of the lipid
membrane. Echinocytogenic amphiphiles are thought to be equilibrated
mainly in the outer monolayer so as to expand it with respect to the
inner, whereas stomatogenic amphiphiles are considered to interact
mainly with the inner monolayer, thus expanding it relative to the
outer. Both HlyA and ProHlyA have been clearly shown to stabilize the
echinocyte shape, thus indicating that both proteins intercalate
preferentially in the outer monolayer. These present ﬁndings are in
agreement with the results reported previously by Soloaga et al. using
freeze–fracture electron microscopy of HlyA-treated liposomes [41].
On the basis of their results, they postulated that HlyA acts as a
nontransmembrane intrinsic protein that induces a transient bilayer
breakdown so as to result in a leakage of liposome contents. This mech-
anism could apply to the destabilization of erythrocyte membranes as
well. Nevertheless, in contrast tomembranemodel systems, in the com-
plex biologic environment of the living-cell membrane many different
signalling pathways could be activated by the interaction of the toxin
that could account for the responses observed here.
Time-lapse analysis revealed differential shape transitions in HlyA-
and ProHlyA-treated erythrocytes. ProHlyA stabilized the echinocyticshape of erythrocytes with no further changes in morphology being ob-
served thereafter. In contrast, HlyA induced spherocytosis before the
hemolysis of rabbit erythrocytes occurred. The discocyte-echinocyte-
spherocyte sequence of morphologic changes observed for HlyA is the
same one occurring with amphiphiles that induce exovesicle formation
[42,43]. Within this context, the release of exovesicles by platelets has
been demonstrated to be commonly induced by stimuli leading to a
rise in intracellular Ca2+ and cytoskeleton remodelling through calpain
activation [44]. These effects, together with a loss of membrane asym-
metry, lead to an outward budding of exovesicles from the membrane
(cf. the review in reference [45]). In addition, ATP binding to P2X7 re-
ceptors on myeloid cells has been shown to stimulate the excretion of
such vesicles [46]. All these events—i. e., the binding of ATP to P2X7 re-
ceptors, the increase in intracellular-Ca2+ levels, and the calpain activa-
tion, among others—have been recently characterized bymany research
groups including ourselves (cf. Figs. 2 and 3) in HlyA-treated erythro-
cytes [23,22,19]. Thus, the possibility that the interaction of HlyA with
the erythrocyte membrane may be triggering the excretion of these
vesicles should not be discarded, though that hypothesis needs further
investigation.
Regarding the role of Ca2+, an inﬂux of that cation occurs in a bi-
phasic manner in HlyA-treated cells, with a ﬁrst step-like increment
followed by a second increase that continues to rise until lysis occurs,
as reported previously [23] and also investigated further here (Fig. 2).
In the presentworkwe have furthermore demonstrated that the second
Ca2+ elevation decreased, along with hemolysis, when the Ca2+ chan-
nels were inhibited by channel blockers like Ni2+ or BBG (Fig. 5), thus
conﬁrming that an activation of endogenous Ca2+ channels is needed
for the lysis of rabbit erythrocytes. Skals et al. have recently proposed
that the ATP efﬂux through toxin pores in the erythrocyte membrane
is responsible for the activation of purinergic channels [30]. Little infor-
mation is available in the literature regarding the purinergic receptors
expressed in rabbit erythrocytes. Within this context, we assume that,
as in other mammalian erythrocytes, the rabbit cells could express
both ligand-gated ion channels—i. e., the P2X and G protein-coupled
(P2Y) receptors [47,48]. Skals et al. have proposed that the P2X7 pro-
teins are the activated purinergic receptors in human erythrocytes
treated with HlyA [20], at a K0.5 of 100–300 μM for the ATP ligand
[49]. The results obtained here indicate that, as in human erythrocytes
[20], so in rabbit erythrocytes, purinergic receptors are involved in the
ampliﬁcation of the hemolytic process produced by HlyA, with those
purinergic channels being responsible in the rabbit erythrocytes for
the acute increase in intracellular Ca2+ that ends in cell lysis. We need
to emphasize at this point, that an increase in the extracellular ATP con-
tent is not in itself enough to produce the massive hemolysis observed
after HlyA insertion since incubation with ATP caused only a modest in-
crease in cell lysis in ProHlyA-treated erythrocytes. In addition to a
purinergic-signalling ampliﬁcation, the ﬁrst increase in Ca2+ levels trig-
gered by the toxin could not be inhibited by the Ca2+-channel blockers
tested, thus indicating that a different pathwaywas responsible for that
ﬁrst step-like Ca2+ increase that occurred after exposure to the toxin.
HlyA is widely assumed to form pores of approximately 2 to 3 nm in di-
ameter in the membrane that could account for the initial Ca2+ entry
observed, although this information is based on indirect measurements
derived from osmotic-protection experiments and electrophysiological
studies [50–52]. In fact, electron microscopy, crystal-structure analysis,
and other techniques have failed to directly reveal the pores formed
by HlyA, so that the existence of such a toxin pore in the target-cell
membrane still remains controversial. Oneprobable difﬁculty in observ-
ing such a pore could be the formation of highly dynamic structures of a
proteolipidic nature by HlyA, whose conductance and membrane life-
time would be dependent on the membrane-lipid composition, as has
been proposed by Bakás et al. [53].
Fatty acids covalently bound to the toxin have been considered to be
responsible for inducing a molten-globule conformation in the protein
that may favor protein-protein interactions along with the occurrence
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these aspects, and taking into account the results obtained here for
HlyA and ProHlyA, we are tempted to propose that the ﬁrst increase in
Ca2+ levels in HlyA-treated erythrocytes might occur as a result of the
HlyA-speciﬁc nature of the perturbation induced by this toxin in the
erythrocytemembrane, since ProHlyA could not effect that initial eleva-
tion. That ﬁrst Ca2+ inﬂux could be counteracted by the Ca2+ efﬂuxes
from the cell since only when the purinergic receptors are activated,
does the sustained Ca2+ entry through these channels produce the
ionic imbalance that ﬁnally ends in cell swelling and erythrocyte lysis.
Nevertheless, when no Ca2+ inﬂux through purinergic channels occurs,
the erythrocytes stay in a spherocyte shape.
In summary; the results presented here indicate that both proteins,
the hemolytically active HlyA and the inactive ProHlyA, induce cell
crenation in rabbit erythrocytes, with this transformation being a
Ca2+-independent phenomenon: the mere interaction of the proteins
with the erythrocyte membrane induces morphologic changes in the
cell. Within this context, both proteins could intercalate in the outer
monolayer of the rabbit-erythrocyte membrane so as to produce the
discocyte-to-echinocyte–shape transition. Nevertheless, only HlyA, the
acylated toxin–throughmembrane destabilization and/or the activation
of transductional pathways–can affect the inﬂux of Ca2+, and presum-
ably the release of exovesicles, that lead to an intermediate spherocyte
shape and ﬁnally a swelling and lysis as a result of the massive entry
of the cation through purinergic channels.
Supplementary data to this article can be found online at http://dx.
doi.org/10.1016/j.bbamem.2016.05.013.
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